Adverse effects of chenodeoxycholic-acid therapy
Brunner, H.; Horak, W.; Grabner, G.
Zeitschrift für Gastroenterologie. Verhandlungsband 9: 55-59
1976
ISSN/ISBN: 0172-8504 PMID: 64086 Document Number: 108848
Document emailed within 1 workday
Related Documents
Dowling, R.H. 1977: Chenodeoxycholic acid therapy of gallstones Clinics in Gastroenterology 6(1): 141-163Sauer, H.D.; de Heer, K.; Mitschke, H. 1979: Chenodeoxycholic acid therapy and colorectal carcinoma--an experimental approach Zeitschrift für Gastroenterologie 17(4): 236-243
Hartmann, W.; Paulini, K.; Goebell, H. 1980: Light and electron microscopy of human liver before and during chenodeoxycholic acid therapy Hepato-Gastroenterology 27(2): 91-98
Sawada, K.; Kawaura, A.; Tanida, N.; Shimoyama, T. 1986: Short-term observation on the behavior of intrarectally instilled chenodeoxycholic acid, lithocholic acid and 5 beta-chol-3-en-24-oic acid in rats Tokushima Journal of Experimental Medicine 33(3-4): 29-37
Iser, J.H.; Murphy, G.M.; Dowling, R.H. 1975: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? the speed of change in biliary lipids and bile acids after starting and stopping treatment Gut 16(10): 840
Ricciardi, S.; Cerqua, R. 1977: Controlled double-blind trial on the clinical effects of the chenodeoxycholic acid-fentonium bromide combination in the symptomatic treatment of biliary spastic-dyskinetic conditions Arzneimittel-Forschung 27(6): 1226-1230
Simanowski, U.A.; Seitz, H.K.; Czygan, P.; Hörner, M.; Waldherr, R.; Weber, E.; Kommerell, B. 1987: Chronic ursodeoxycholic acid- and chenodeoxycholic acid-feeding-induced changes of colon mucosal cell proliferation in rats Journal of the National Cancer Institute 79(1): 163-166
Berman, H.; Betourne, C.; Brette, R.; Chaput, J.C.; Debray, C.; Etienne, J.P.; Gerolami, A.; Paraf, A.; Paris, J.; Petite, J.P.; Rautureau, J.; Sarles, H. 1977: Medical treatment of biliary cholesterol lithiasis by chenodeoxycholic acid (chenic acid). French multicenter controlled test La Nouvelle Presse Medicale 6(1): 41-43
Bursaux, C.D. 1975: Toxicity of chenodeoxycholic acid Medecine and Chirurgie Digestives 4(Suppl): 13-14
Giuseppetti, G.; Paciotti, M. 1978: Polymorphism of chenodeoxycholic acid Il Farmaco; Edizione Scientifica 33(1): 64-72
Stiehl, A.; Ast, E.; Czygan, P.; Fröhling, W.; Kommerell, B. 1976: Serum transaminases and bile acid concentrations in the serum of patients with biliary calculi during treatment with chenodeoxycholic acid Zeitschrift für Gastroenterologie. Verhandlungsband 9: 40-41
Andersen, J.M. 1979: Chenodeoxycholic acid desaturates bile--but how? Gastroenterology 77(5): 1146-1151
Rautureau, J.; Rautureau, M.; Coste, T. 1975: Biological data on chenodeoxycholic acid Medecine and Chirurgie Digestives 4(Suppl 1): 7-11
Brändli, H.H.; Hefti, M.L.; Blum, A.L. 1977: Dissolution of gallstones by chenodeoxycholic acid Schweizerische Medizinische Wochenschrift 107(48): 1770-1773
Devilat, M.; Blumel, J.E. 1991: Adverse effects of valproic acid in epileptic infants and adolescents Revista Chilena de Pediatria 62(6): 362-366
Friis, B.; Thomsen, J. 1979: Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin Ugeskrift for Laeger 141(29): 1968-1972
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Wereszczyńska-Siemiatkowska, U.; Baniukiewicz, A.; Gabryelewicz, A. 1988: Treatment of cholesterol cholelithiasis with chenodeoxycholic acid Wiadomosci Lekarskie 41(4): 221-226
Schalm, S.W.; van Berge Henegouwen, G.P. 1978: Treatment of patients with gallstones with chenodeoxycholic acid Nederlands Tijdschrift Voor Geneeskunde 122(8): 266-270